Recent Updates
Recently added Catalysts
HELP Positive Sentiment

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Thursday, September 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Helus Pharma will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York. CEO Michael Halstead is scheduled for a fireside chat on September 16, 2026, at 8:30 a.m. EDT. This event highlights the company's engagement with the investment community and its ongoing clinical-stage initiatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prestigious healthcare conference
  • Opportunity for CEO to engage with investors
  • Showcases Helus Pharma's commitment to growth

Full Press Release Details

CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT. NEW YORK and TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to

Frequently Asked Questions

When is Helus Pharma's participation in the conference?

Helus Pharma will participate on September 16, 2026.

Who will represent Helus Pharma at the conference?

CEO Michael Halstead will represent Helus Pharma.

What time is the fireside chat scheduled?

The fireside chat is scheduled for 8:30 a.m. EDT.

Where is the Morgan Stanley conference taking place?

The conference is taking place in New York.

ShareAdd on Google
Tags: HELP Viatris Investor Conferences Healthcare Helus Pharma Morgan Stanley healthcare conference CEO Michael Halstead clinical-stage
Last updated: Sep 10, 2026

Biotech snapshot

Lead asset
CYB003Phase 3
Major Depressive Disorder →